Eisai Beats Whistleblower's Off-Label Marketing FCA Suit

Law360, New York (February 01, 2013, 3:33 PM ET) -- A Florida federal judge on Friday tossed an employee whistleblower's False Claims Act suit accusing pharmaceutical company Eisai Inc. of promoting off-label uses for its drugs and paying medical providers to use its drugs in unapproved ways.

U.S. District Judge Kathleen M. Williams said qui tam relator Michael Keeler failed to plead key, particular elements of the alleged fraud, triggering the dismissal of the case on procedural grounds.

“Relator has failed to set forth a claim under even the minimal pleading requirements recognized by long-standing and...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

United States of America et al v. Eisai, Inc. et al


Case Number

1:09-cv-22302

Court

Florida Southern

Nature of Suit

Other Statutory Actions

Judge

Kathleen M. Williams

Date Filed

August 4, 2009

Law Firms

Companies

Government Agencies